134 related articles for article (PubMed ID: 25534583)
1. Comprehensive profiling analysis of actively resorbing osteoclasts identifies critical signaling pathways regulated by bone substrate.
Purdue PE; Crotti TN; Shen Z; Swantek J; Li J; Hill J; Hanidu A; Dimock J; Nabozny G; Goldring SR; McHugh KP
Sci Rep; 2014 Dec; 4():7595. PubMed ID: 25534583
[TBL] [Abstract][Full Text] [Related]
2. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways.
Choi HJ; Park YR; Nepal M; Choi BY; Cho NP; Choi SH; Heo SR; Kim HS; Yang MS; Soh Y
Eur J Pharmacol; 2010 Jun; 636(1-3):28-35. PubMed ID: 20353769
[TBL] [Abstract][Full Text] [Related]
5. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways.
Gramoun A; Azizi N; Sodek J; Heersche JN; Nakchbandi I; Manolson MF
J Cell Biochem; 2010 Nov; 111(4):1020-34. PubMed ID: 20672308
[TBL] [Abstract][Full Text] [Related]
7. Anti-apoptotic Bcl-2 family member Mcl-1 regulates cell viability and bone-resorbing activity of osteoclasts.
Masuda H; Hirose J; Omata Y; Tokuyama N; Yasui T; Kadono Y; Miyazaki T; Tanaka S
Bone; 2014 Jan; 58():1-10. PubMed ID: 24096094
[TBL] [Abstract][Full Text] [Related]
8. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
9. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
Kim HN; Lee JH; Jin WJ; Ko S; Jung K; Ha H; Lee ZH
Eur J Pharmacol; 2012 Sep; 691(1-3):69-76. PubMed ID: 22846626
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha.
van Beek EM; de Vries TJ; Mulder L; Schoenmaker T; Hoeben KA; Matozaki T; Langenbach GE; Kraal G; Everts V; van den Berg TK
FASEB J; 2009 Dec; 23(12):4081-90. PubMed ID: 19667119
[TBL] [Abstract][Full Text] [Related]
11. Partial loss of Smad7 function impairs bone remodeling, osteogenesis and enhances osteoclastogenesis in mice.
Li N; Lee WY; Lin SE; Ni M; Zhang T; Huang XR; Lan HY; Li G
Bone; 2014 Oct; 67():46-55. PubMed ID: 24998669
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
Chang EJ; Kim HJ; Ha J; Kim HJ; Ryu J; Park KH; Kim UH; Lee ZH; Kim HM; Fisher DE; Kim HH
J Cell Sci; 2007 Jan; 120(Pt 1):166-76. PubMed ID: 17164294
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors.
Zhao B; Ivashkiv LB
Arthritis Res Ther; 2011 Jul; 13(4):234. PubMed ID: 21861861
[TBL] [Abstract][Full Text] [Related]
14. Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts.
Kim H; Kim IY; Lee SY; Jeong D
FEBS Lett; 2006 Oct; 580(24):5661-5. PubMed ID: 16996506
[TBL] [Abstract][Full Text] [Related]
15. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
[TBL] [Abstract][Full Text] [Related]
16. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
[TBL] [Abstract][Full Text] [Related]
18. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
[TBL] [Abstract][Full Text] [Related]
19. α-Tocotrienol inhibits osteoclastic bone resorption by suppressing RANKL expression and signaling and bone resorbing activity.
Ha H; Lee JH; Kim HN; Lee ZH
Biochem Biophys Res Commun; 2011 Mar; 406(4):546-51. PubMed ID: 21352805
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: reciprocal roles of Tspan-5 and NET-6 during osteoclastogenesis.
Iwai K; Ishii M; Ohshima S; Miyatake K; Saeki Y
Allergol Int; 2007 Dec; 56(4):457-63. PubMed ID: 17965585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]